Lentiviral Gene Therapy with CD34+ Hematopoietic Cells for Hemophilia A
New England Journal of Medicine · 30.01.2025 · 392 (5) · 450-457
DOI: 10.1056/nejmoa2410597 ↗Kurz gefasst
Klinische Studie (Phase I) in der Zeitschrift New England Journal of Medicine, erschienen am 30.01.2025. Verfasst von Alok Srivastava und 22 weiteren Autor:innen. Beteiligte Einrichtung: From the Department of Hematology, Christian Medical College Vellore, Ranipet Campus, Vellore, India (A.S., A.A., F.A., U.K., S.S., A.K., A.S.S., A.J…. Hauptthemen laut MEDLINE: Factor VIII, Genetic Therapy, Hematopoietic Stem Cell Transplantation, Hemophilia A. Die Arbeit wurde bisher 64-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Hemophilia of Georgia, NHLBI NIH HHS, Department of Biotechnology, Ministry of Science and Technology, India.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- From the Department of Hematology, Christian Medical College Vellore, Ranipet Campus, Vellore, India (A.S., A.A., F.A., U.K., S.S., A.K., A.S.S., A.J., N.K., C.B., K.M.L., R.V.S.); Center for Stem Cell Research Unit of…
ORCID-Profile: Uday Kulkarni
Förderung
- Hemophilia of Georgia
- NHLBI NIH HHS
- Department of Biotechnology, Ministry of Science and Technology, India
- National Heart, Lung, and Blood Institute
Zitieren
APA
Srivastava, A., Abraham, A., Aboobacker, F., Singh, G., Geevar, T., Kulkarni, U., Selvarajan, S., Korula, A., Dave, R. G., Shankar, M., Singh, A. S., Jeba, A., Kumaar, N., Benjamin, C., Lakshmi, K. M., Srivastava, V. M., Shaji, R. V., Nair, S. C., Brown, H. C., …, & Spencer, T. (2025). Lentiviral Gene Therapy with CD34+ Hematopoietic Cells for Hemophilia A. New England Journal of Medicine, 392(5), 450-457. https://doi.org/10.1056/nejmoa2410597
Vancouver
Srivastava A, Abraham A, Aboobacker F, Singh G, Geevar T, Kulkarni U, et al. Lentiviral Gene Therapy with CD34+ Hematopoietic Cells for Hemophilia A. New England Journal of Medicine. 2025;392(5):450-457. doi:10.1056/nejmoa2410597
BibTeX
@article{Srivastava2025,
author = {Srivastava, Alok and Abraham, Aby and Aboobacker, Fouzia and Singh, Gurbind and Geevar, Tulasi and Kulkarni, Uday and Selvarajan, Sushil and Korula, Anu and Dave, Rutvi Gautam and Shankar, Mohana and Singh, Abraham S and Jeba, Anbu and Kumaar, Navien and Benjamin, Christopher and Lakshmi, Kavitha M and Srivastava, Vivi Miriam and Shaji, Ramachandran V and Nair, Sukesh C and Brown, Harrison C and Denning, Gabriela and Lollar, Pete and Doering, Christopher B and Spencer, Trent},
title = {Lentiviral Gene Therapy with CD34+ Hematopoietic Cells for Hemophilia A},
journal = {New England Journal of Medicine},
year = {2025},
volume = {392},
number = {5},
pages = {450--457},
doi = {10.1056/nejmoa2410597}
}
EUVIMED